NEXGEL (NXGL) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
24 Dec, 2025Executive summary
Achieved record revenue growth in Q4 2024 ($3.04M, up 181% YoY) and FY 2024 ($8.69M, up 112% YoY), marking the third consecutive year of over 100% growth.
Growth driven by branded consumer products and contract manufacturing, with new partnerships, product launches, and acquisitions fueling expansion.
Strategic focus on innovation, expanding product lines, and entering new markets, including beauty and medical device segments.
Acquired Silly George, expanding its sales from $2M to over $5M annual run rate.
Announced supply agreement with Cintas and partnership with STADA for new product launches.
Financial highlights
Q4 2024 revenue reached $3.04M, up 181% YoY; FY 2024 revenue was $8.69M, up 112%.
Q4 gross margin was 37.2% (down from 43.6% in Q3 due to reclassification of Amazon commissions); FY 2024 gross margin was 31.6%.
Q4 net loss was $0.85M (improved from $1.1M in Q4 2023); FY 2024 net loss was $3.28M.
Q4 EBITDA loss was $0.73M; adjusted EBITDA loss was $0.62M.
Two one-time inventory write-offs totaling $243K impacted Q4 results.
Outlook and guidance
Q1 2025 revenue expected to be at least $2.75M, despite seasonality.
2025 revenue guidance of at least $13M, with positive EBITDA targeted during the year.
Anticipates improved adjusted EBITDA in Q1 2025 and expects new customer ramp-up in Q2.
Pipeline of new customers for 2025 described as healthy and robust.
Latest events from NEXGEL
- Hydrogel innovation and strategic partnerships fuel rapid growth and expanding product lines.NXGL
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - Record Q2 revenue and strong outlook driven by branded products and Silly George growth.NXGL
Q2 20242 Feb 2026 - Q3 revenue up 141% to $2.94M, gross margin 43.6%, but losses and risks persist.NXGL
Q3 202414 Jan 2026 - Strong growth from product innovation, acquisitions, and major partnerships, with profitability in focus.NXGL
IAccess Alpha–Buyside Best Ideas Winter Virtual Conference 202411 Jan 2026 - Shareholders will vote on director elections, incentive plan expansion, and executive pay, all backed by the Board.NXGL
Proxy Filing2 Dec 2025 - Vote to increase authorized common stock to 1B shares for future flexibility is recommended.NXGL
Proxy Filing2 Dec 2025 - Q1 2025 revenue up 121%, margin at 42.4%, and positive EBITDA targeted for 2025.NXGL
Q1 202527 Nov 2025 - Q2 2025 revenue doubled and margins improved, but going concern risks persist.NXGL
Q2 202523 Nov 2025 - Q3 revenue steady at $2.93M, gross margin up, nine-month revenue up 52.7%, risks persist.NXGL
Q3 202517 Nov 2025